Viewing Study NCT07081503


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-29 @ 9:44 AM
Study NCT ID: NCT07081503
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of ADX-626 in Healthy Participants
Sponsor: ADARx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module